11892 J. Am. Chem. Soc., Vol. 120, No. 46, 1998
Ito et al.
Iodo[3′′-(7′-methoxy[1,1′-binaphthalene]-2-yl)-6,6′,7,7′-tetrakis-
(methoxymethyl)-5,5′,8,8′-tetramethyl-5′′,8′′-bis(4-methylphenyl)-
[2,2′:3′,2′′-terquinoxalin]-3-yl]bis(trimethylphosphine)palladium
(172): 1H NMR (500 MHz, C6D6) δ 0.72 (d, J ) 7.1 Hz, 9H), 1.12 (d,
J ) 7.1 Hz, 9H), 1.93 (s, 3H), 2.02 (s, 3H), 2.29 (s, 3H), 2.34 (s, 3H),
2.91 (s, 3H), 2.95 (s, 3H), 2.98 (s, 3H), 3.13 (s, 3H), 3.14 (s, 3H), 3.15
(s, 3H), 3.54 (s, 3H), 4.25 (d, J ) 11.2 Hz, 2H), 4.34 (d, J ) 11.2 Hz,
1H), 4.38 (d, J ) 11.2 Hz, 1H), 4.49 (d, J ) 10.8 Hz, 1H), 4.54 (d, J
) 10.8 Hz, 1H), 4.56-4.62 (m, 2H), 6.61 (d, J ) 7.9 Hz, 2H), 6.70
(d, J ) 7.9 Hz, 2H), 6.87 (d, J ) 7.9 Hz, 2H), 6.93 (t, J ) 8.3 Hz,
1H), 7.00 (d, J ) 7.7 Hz, 1H), 7.01 (d, J ) 7.9 Hz, 2H), 7.03 (t, J )
8.3 Hz, 1H), 7.05 (d, J ) 2.2 Hz, 1H), 7.09 (t, J ) 7.1 Hz, 1H), 7.23
(d, J ) 7.7 Hz, 1H), 7.25 (d, J ) 8.8 Hz, 1H), 7.28 (dd, J ) 9.0, 2.2
Hz, 1H), 7.32 (d, J ) 8.3 Hz, 1H), 7.48 (d, J ) 7.1 Hz, 1H), 7.60 (d,
J ) 9.0 Hz, 1H), 7.66 (d, J ) 8.3 Hz, 1H), 8.46 (d, J ) 8.6 Hz, 1H),
8.67 (d, J ) 7.1 Hz, 1H); 31P NMR (C6D6) δ -23.65 (d, J ) 392 Hz),
-22.66 (d, J ) 392 Hz). Anal. Calcd for C77H81IN6O5P2Pd: C, 63.09;
H, 5.57; N, 5.73. Found: C, 63.12; H, 5.53; N, 5.67. FABMS (pos)
calcd signals (intensity/% based on MH+) for [C77H81IN6O5P2Pd + H]+:
m/z 1463 (22), 1464 (63), 1465 (100), 1466 (67), 1467 (78), 1468
(53), 1469 (45), 1470 (27), 1471 (11). Found: m/z 1463 (45), 1464
(75), 1465 (100), 1466 (75), 1467 (79), 1468 (53), 1469 (41), 1470
(18), 1471 (9). Deuterated derivatives 172-i-iv were prepared similarly
by reactions of 16′ or 16′′ and identified by 1H NMR and MS.
Compound 172-i: 1H NMR (C6D6) showed signals identical to that
for 172 except for disappearance of singlets at 2.02, 2.34, 3.15, and
3.54 ppm. FABMS (pos) m/z 1477 (MH+). Compound 172-ii: 1H
NMR (C6D6) showed signals identical to that for 172 except for
disappearance of singlets at 2.95, 2.98, 3.13, and 3.14 ppm. FABMS
(pos) m/z 1477 (MH+). Compound 172-iii: 1H NMR (C6D6) showed
signals identical to that for 172 except for disappearance of singlets at
2.02 and 3.15 ppm. FABMS (pos) m/z 1471 (MH+). Compound 172-
iv: 1H NMR (C6D6) showed signals identical to that for 172 except for
disappearance of singlets at 2.98 and 3.13 ppm. FABMS (pos) m/z
1471 (MH+).
Synthesis of 181 and 182. To a solution of 4a′ (99 mg, 0.1 mmol)
in THF (mL) was added 16 (50 mg, 0.2 mmol) at room temperature.
The mixture was stirred at room temperature for 10 h. Evaporation of
the solvent gave a crude mixture of [oligo(quinoxalinyl)]palladium(II)
complexes, which was subjected to preparative GPC to afford 181 (30
mg, 22%) and 182 (48 mg, 31%) together with higher oligomers (39
mg) and recovered starting complex 4d′ (8 mg, 8%).
Iodo[3′-(2′-methoxy[1,1′-binaphthalene]-2-yl)-6,7-bis(methoxy-
methyl)-5,8-dimethyl-5′,8′-bis(4-methylphenyl)[2,2′-biquinoxalin]-
3-yl]bis(trimethylphosphine)palladium (181): 181: 1H NMR (C6D6)
δ 0.55 (br s, 9H), 0.81 (br s, 9H), 2.20 (s, 3H), 2.23 (s, 3H), 2.30-
2.90 (br, 6H), 2.97 (br s, 3H), 3.24 (s, 3H), 3.26 (br s, 3H), 4.68 (br s,
3H), 4.72 (s, 3H), 6.50-7.68 (m, 20H), 7.96 (br s, 2H); 31P NMR (C6D6)
δ 22.5 (br). FABMS (pos) calcd signals (intensity/% based on MH+)
for [C63H65IN4O3P2Pd + H]+: m/z 1219 (25), 1220 (65), 1221 (100),
1222 (57), 1223 (76), 1224 (46), 1225 (41). Found: m/z 1219 (29),
1220 (80), 1221 (100), 1222 (79), 1223 (65), 1224 (43), 1225 (32).
Iodo[3′′-(2′-methoxy[1,1′-binaphthalene]-2-yl)-6,6′,7,7′-tetrakis-
(methoxymethyl)-5,5′,8,8′-tetramethyl-5′′,8′′-bis(4-methylphenyl)-
[2,2′:3′,2′′-terquinoxalin]-3-yl]bis(trimethylphosphine)palladium (182).
This compound was obtained as a mixture of two diastereomers ((P)-
(S)-isomer: (M)-(S)-isomer ) 52:48). 182: 1H NMR (500 MHz,
C6D6: (P)-(S)- and (M)-(S)-isomers are denoted by isomer A and B,
respectively, in the following description) δ 0.71 (d, J ) 6.1 Hz, 9H
for isomer A), 0.75 (s, 9H for isomer B), 1.10 (s, 9H for isomers A
and B), 1.89 (s, 3H for isomer A), 1.93 (s, 3H for isomer B), 2.20 (s,
3H for isomer B), 2.22 (s, 3H for isomer B), 2.24 (s, 3H for isomer
B), 2.30 (s, 3H for isomer A), 2.38 (s, 3H for isomer A), 2.53 (s, 3H
for isomer A), 2.92-3.22 (m, 18 H for isomers A and B), 3.64 (s, 3H
for isomers A and B), 4.20-4.58 (m, 6H for isomers A and B), 4.58-
4.72 (m, 2H for isomers A and B), 6.40-7.70 (m, 19 H for isomers A
and B), 7.78-8.00 (m, 1H for isomer A and 2H for isomer B), 8.34
(br s, 1H for isomer B), 8.44 (d, J ) 8.6 Hz, 1H for isomer A), 8.90
(d, J ) 7.7 Hz, 1H for isomer A); 31P NMR (C6D6) δ -23.8, -23.64,
-23.59, -23.4. FABMS (pos) calcd signals (intensity/% based on
MH+) for [C77H81IN6O5P2Pd + H]+: m/z 1463 (22), 1464 (63), 1465
(100), 1466 (67), 1467 (78), 1468 (53), 1469 (45), 1470 (27), 1471
(11). Found: m/z 1463 (58), 1464 (74), 1465 (100), 1466 (77), 1467
(74), 1468 (54), 1469 (47), 1470 (29), 1471 (25). 182-i: 1H NMR
(500 MHz, C6D6: (P)-(S)- and (M)-(S)-isomers are denoted by isomer
A and B, respectively, in the following description) δ 0.71 (d, J ) 6.1
Hz, 9H for isomer A), 0.75 (s, 9H for isomer B), 1.10 (s, 9H for isomers
A and B), 1.89 (s, 3H for isomer A), 1.93 (s, 3H for isomer B), 2.24
(s, 3H for isomer B), 2.30 (s, 3H for isomer A), 2.95-3.22 (m, 15 H
for isomers A and B), 4.20-4.58 (m, 6H for isomers A and B), 4.58-
4.72 (m, 2H for isomers A and B), 6.40-7.70 (m, 19 H for isomers A
and B), 7.78-8.00 (m, 1H for isomer A and 2H for isomer B), 8.34
(br s, 1H for isomer B), 8.44 (d, J ) 8.6 Hz, 1H for isomer A), 8.90
(d, J ) 7.7 Hz, 1H for isomer A). FABMS (pos) m/z 1477 [C77H69D12-
IN6O5P2Pd + H]+.
Synthesis of 192-i. To a solution of 4b′ (67 mg, 0.071 mmol) in
THF (mL) was added 16′ (36 mg, 0.142 mmol) at room temperature.
The mixture was stirred at room temperature for 10 h. Evaporation of
the solvent gave a crude mixture of [oligo(quinoxalinyl)]palladium(II)
complexes, which was subjected to preparative GPC to afford 192-i
(49 mg, 48%). 192-i: 1H NMR (500 MHz, C6D6) δ 0.71 (d, J ) 7.2
Hz, 9H), 1.13 (d, J ) 7.2 Hz, 9H), 1.93 (s, 3H), 2.22 (s, 3H), 2.93 (s,
3H), 2.95 (s, 3H), 3.14 (s, 3H), 3.15 (s, 3H), 4.25-4.40 (m, 4H), 4.49-
4.62 (m, 4H), 6.56 (d, J ) 7.4 Hz, 2H), 6.69 (d, J ) 7.9 Hz, 2H), 6.72
(d, J ) 7.5 Hz, 2H), 6.88 (t, J ) 7.9 Hz, 1H), 6.95-7.31 (m, 10H),
7.49-7.54 (m, 2H), 7.67-7.72 (m, 2H), 8.47 (d, J ) 8.6 Hz, 1H),
8.57 (d, J ) 6.6 Hz, 1H); 31P NMR (C6D6) δ -22.9, -23.3. FABMS
(pos) calcd signals (intensity/% based on MH+) for [C76H67D12IN6O4P2-
Pd + H]+: m/z 1445 (22), 1446 (63), 1447 (100), 1448 (66), 1449
(78), 1450 (53), 1451 (44), 1452 (26), 1453 (10). Found: m/z 1445
(47), 1446 (83), 1447 (100), 1448 (78), 1449 (76), 1450 (58), 1451
(42), 1452 (29), 1453 (12).
Iodo[3′′′-(7′-methoxy[1,1′-binaphthalene]-2-yl)-6,6′,6′′,7,7′,7′′-
hexakis(methoxymethyl)-5,5′,5′′,8,8′,8′′-hexamethyl-5′′′,8′′′-bis(4-
methylphenyl)[2,2′:3′,2′′:3′<bold>′,2′′′-quaterquinoxalin]-3-yl]bis-
(trimethylphosphine)palladium (173): 1H NMR (400 MHz, C6D6) δ
1.03 (d, J ) 7.3 Hz, 9H), 1.23 (d, J ) 7.3 Hz, 9H), 1.74 (s, 6H), 1.77
(s, 3H), 2.26 (s, 6H), 2.30 (s, 3H), 2.87 (s, 3H), 2.95 (s, 3H), 2.96 (s,
3H), 3.02 (s, 3H), 3.08 (s, 3H), 3.12 (s, 3H), 3.20 (s, 3H), 3.22 (s, 3H),
3.43 (s, 3H), 4.18 (d, J ) 11.2 Hz, 1H), 4.27-4.47 (m, 8H), 4.57 (d,
J ) 11.2 Hz, 1H), 4.65 (d, J ) 10.6 Hz, 1H), 4.69 (d, J ) 10.6 Hz,
1H), 6.65 (d, J ) 8.1 Hz, 2H), 6.79 (t, J ) 9.2 Hz, 1H), 6.9-7.0 (m,
4H), 7.1-7.2 (m, 6H), 7.24 (dd, J ) 2.4, 9.2 Hz, 1H), 7.31-7.36 (m,
3H), 7.41 (d, J ) 8.4 Hz, 1H), 7.53 (d, J ) 9.2 Hz, 1H), 7.70 (d, J )
8.4 Hz, 1H), 8.48-8.50 (m, 2H); 31P NMR (C6D6) δ -23.03, -23.76.
FABMS (pos) calcd signals (intensity/% based on MH+) for [C91H97-
IN8O7P2Pd + H]+: m/z 1707 (20), 1708 (60), 1709 (100), 1710 (76),
1711 (82), 1712 (61), 1713 (50), 1714 (32). Found: m/z 1707 (60),
1708 (76), 1709 (100), 1710 (71), 1711 (60), 1712 (53), 1713 (42),
1714 (37).
Iodo[3′′′′-(7′-methoxy[1,1′-binaphthalene]-2-yl)-6,6′,6′′,6′′′,7,7′,7′′,7′′′-
octakis(methoxymethyl)-5,5′,5′′,5′′′,8,8′,8′′,8′′′-octamethyl-5′′′′,8′′′′-
bis(4-methylphenyl)[2,2′:3′,2′′:3′<bold>′,2′′′:3′′′,2′′′′-quinquequin-
oxalin]-3-yl]bis(trimethylphosphine)palladium (174): 1H NMR (400
MHz, C6D6) δ 1.20 (dd, J ) 5.4, 1.6 Hz, 9H), 1.30 (dd, J ) 5.4, 1.6
Hz, 9H), 1.62 (s, 3H), 1.92 (s, 3H), 2.09 (s, 3H), 2.10 (s, 3H), 2.11 (s,
3H), 2.13 (s, 3H), 2.23 (s, 3H), 2.29 (s, 3H), 2.78 (s, 3H), 2.80 (s, 3H),
2.84 (s, 3H), 2.93 (s, 3H), 2.94 (s, 3H), 2.98 (s, 3H), 3.14 (s, 3H), 3.17
(s, 3H), 3.20 (s, 3H), 3.70 (s, 3H), 4.0-4.4 (m, 12H), 4.5-4.7 (m,
4H), 6.61 (d, J ) 8.1 Hz, 2H), 6.65 (d, J ) 8.1 Hz, 2H), 6.77 (d, J )
7.7 Hz, 2H), 6.90-7.03 (m, 4H), 7.1-7.2 (m, 3H), 7.25-7.35 (m, 2H),
7.4-7.5 (m, 2H), 7.55 (d, J ) 8.1 Hz, 1H), 7.65-7.70 (m, 2H), 8.69
(d, J ) 8.6 Hz, 1H), 8.76 (d, J ) 6.2 Hz, 1H); 31P NMR (C6D6) δ
-23.57, -23.68. FABMS (pos) calcd signals (intensity/% based on
MH+) for [C105H113IN10O9P2Pd + H]+: m/z 1951 (19), 1952 (57), 1953
(100), 1954 (85), 1955 (88), 1956 (69), 1957 (56), 1958 (37), 1959
(18). Found: m/z 1951 (56), 1952 (74), 1953 (100), 1954 (92), 1955
(80), 1956 (60), 1957 (43), 1958 (24), 1959 (17).
Synthesis of 202-i. To a solution of 4c′ (44 mg, 0.041 mmol) in
THF (1.5 mL) was added 16′ (21 mg, 0.082 mmol) at room temperature.